LAWSUIT CLAIMS PAXIL IS ADDICTIVE

LOS ANGELES -- A lawsuit contends the manufacturer of the popular
anti-depressant Paxil concealed evidence that the drug can be addictive.

The lawsuit was filed Friday on behalf of 35 people from around the country
who say they suffered symptoms ranging from electric-like shocks to
suicidal thoughts after discontinuing use of the drug.

The lawsuit, which seeks class-action status and unspecified damages, says
GlaxoSmithkline PLC concealed the possibility of physical and psychological
withdrawal symptoms from the drug. It alleges fraud, deceit, negligence,
liability, and breach of warranty.

There was no immediate comment from the British-based company. Calls to its
U.S. offices after business hours Friday were not returned.

Introduced on the U.S. market in 1992, Paxil is the country's
second-largest selling anti-depressant.

Paul Domb, 42, of Miami, said that after he stopped taking Paxil last year,
he suffered from convulsions, night sweats, and suicidal thoughts for about
six weeks.

He said he thought the problems had to do with recent heart surgery, but
after researching his symptoms he concluded they were caused by his
withdrawal from Paxil.

"I stopped taking this drug . . . and it destroyed me. It almost killed
me," he said.

In June, a Wyoming jury awarded $8 million in damages to the family of a
man after determining that Paxil caused him to kill his wife, daughter and
granddaughter before committing suicide.